T
Toshiya Muramatsu
Researcher at Kyoto University
Publications - 164
Citations - 5299
Toshiya Muramatsu is an academic researcher from Kyoto University. The author has contributed to research in topics: Percutaneous coronary intervention & Stent. The author has an hindex of 32, co-authored 156 publications receiving 4627 citations. Previous affiliations of Toshiya Muramatsu include Wakayama Medical University & Stanford University.
Papers
More filters
Journal ArticleDOI
Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes : The J-CTO (Multicenter CTO Registry in Japan) Score as a Difficulty Grading and Time Assessment Tool
Yoshihiro Morino,Mitsuru Abe,Takeshi Morimoto,Takeshi Kimura,Yasuhiko Hayashi,Toshiya Muramatsu,Masahiko Ochiai,Yuichi Noguchi,Kenichi Kato,Yoshisato Shibata,Yoshikazu Hiasa,Osamu Doi,Takehiro Yamashita,Tomoaki Hinohara,Hiroyuki Tanaka,Kazuaki Mitsudo,J-Cto Registry Investigators +16 more
TL;DR: This model predicted the probability of successful guidewire crossing within 30 min very well and can be applied for difficulty grading.
Journal ArticleDOI
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
Takeshi Kimura,Takeshi Morimoto,Yoshihisa Nakagawa,Toshihiro Tamura,Kazushige Kadota,Hitoshi Yasumoto,Hideo Nishikawa,Yoshikazu Hiasa,Toshiya Muramatsu,Taiichiro Meguro,Naoto Inoue,Hidehiko Honda,Yasuhiko Hayashi,Shunichi Miyazaki,Shigeru Oshima,Takashi Honda,Nobuo Shiode,Masanobu Namura,Takahito Sone,Masakiyo Nobuyoshi,Toru Kita,Kazuaki Mitsudo +21 more
TL;DR: Discontinuation of both thienopyridine and aspirin, but not discontinuation of thienobyridine therapy only, was associated with an increased risk of stent thrombosis in patients undergoing sirolimus-eluting stent implantation.
Journal ArticleDOI
In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan).
Yoshihiro Morino,Takeshi Kimura,Yasuhiko Hayashi,Toshiya Muramatsu,Masahiko Ochiai,Yuichi Noguchi,Kenichi Kato,Yoshisato Shibata,Yoshikazu Hiasa,Osamu Doi,Takehiro Yamashita,Takeshi Morimoto,Mitsuru Abe,Tomoaki Hinohara,Kazuaki Mitsudo,J-Cto Registry Investigators +15 more
TL;DR: Most CTO lesions can be safely and successfully treated with PCI utilizing contemporary advanced techniques, and Invasiveness and potential risks of these strategies may be acceptable in the majority of cases considering the actual incidences of related adverse events and the procedural success rates.
Journal ArticleDOI
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.
Takeshi Kimura,Ken Kozuma,Kengo Tanabe,Sunao Nakamura,Masahisa Yamane,Toshiya Muramatsu,Shigeru Saito,Junji Yajima,Nobuhisa Hagiwara,Kazuaki Mitsudo,Jeffrey J. Popma,Patrick W. Serruys,Patrick W. Serruys,Yoshinobu Onuma,Shih-Wa Ying,Sherry Cao,Peter Staehr,Wai Fung Cheong,Hajime Kusano,Gregg W. Stone +19 more
TL;DR: In the ABSORB Japan randomized trial, 12-month clinical and 13-month angiographic outcomes of BVSs were comparable to CoCr-EESs, and the results support regulatory approval of the Absorb BVS in Japan.
Journal ArticleDOI
Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
Takeshi Kimura,Takeshi Morimoto,Yoshihisa Nakagawa,Kazuya Kawai,Shunichi Miyazaki,Toshiya Muramatsu,Nobuo Shiode,Masanobu Namura,Takahito Sone,Shigeru Oshima,Hideo Nishikawa,Yoshikazu Hiasa,Yasuhiko Hayashi,Masakiyo Nobuyoshi,Kazuaki Mitudo +14 more
TL;DR: In this paper, the authors evaluated five-year outcomes in 12 812 consecutive patients undergoing sirolimus-eluting stent (SES) implantation in the j-Cypher registry.